2023, Packaging, Pharmaceuticals and Pharmacy

DrugBank adds ASHP data to knowledgebase, improving user experience and data reliability

DrugBank

NOVEMBER 7, 2023

EDMONTON, CANADA, November 1st, 2023— DrugBank today kicked off their role as a key distributor of the American Society for Health-System Pharmacists’s (ASHP) data. Discover ASHP Third-Party Packages in the Data Librar y ABOUT DRUGBANK DrugBank is the world’s first intelligent and comprehensive drug knowledge platform.

Pharmacy

Pharmacy Community Pharmacies Packaging Pharmaceutical Companies

Scandinavia: insight into opportunities for drug discovery

Drug Discovery World

FEBRUARY 10, 2023

Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Sweden remains Scandinavia’s powerhouse market for pharmaceutical research and development. Sweden remains Scandinavia’s powerhouse market for pharmaceutical research and development.

Science

Science Drugs Pharmaceutical Companies Pharmaceuticals

European Commission vs Big Pharma, or profit vs access?

Drug Discovery World

MARCH 29, 2023

On January 31 2023, an internally circulated version of the European Commission’s overhaul of the EU’s pharma legislation was leaked, and published by Politico 1.

Clinical Trials

Clinical Trials Biosimilars Pharma Companies Production

Article EMA Thank You New EC report dives deep to better understand shortages of critical medicines

Agency IQ

JULY 12, 2024

In May 2023, a non-paper drafted by the Belgian government, obtained by POLITICO Pro EU, called attention to the continuing issue of medicine supply shortages. In October 2024, the European Commission published a communication putting forth a package of reforms to address medicines shortages. points of disruption).

Regulations

Regulations Packaging Production FDA

Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023

Agency IQ

DECEMBER 1, 2023

What We Expect the FDA to do in December 2023 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA

FDA Science Regulations Production

Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023

Agency IQ

OCTOBER 27, 2023

What We Expect the FDA to do in November 2023 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA

FDA Science Regulations Production

Analysis Life Sciences Thank You After 13-year review, FDA finalizes ‘clear, conspicuous and neutral’ drug advertising rule

Agency IQ

NOVEMBER 27, 2023

Many posted comments came from professional pharmacy organizations, trade groups like the Pharmaceutical Research and Manufacturers of America (PhRMA) , and pharmaceutical companies, such a Eli Lilly , Novo Nordisk and Merck.

FDA

FDA Science Drugs Regulations

Analysis Life Sciences Thank You The 51 regulations that FDA is currently working on

Agency IQ

JUNE 16, 2023

The 51 regulations that FDA is currently working on The FDA today unveiled its much-anticipated Spring 2023 Unified Agenda, a document outlining the regulations the agency plans to release in 2023 and beyond. The latest update, announced this week, is known as the Spring 2023 Unified Agenda.

Regulations

Regulations FDA Science Production

Scaling Phage Therapy

Codon

FEBRUARY 13, 2024

Fast forward to 2023. 3 Another considerable obstacle to pharmaceutical companies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive. Phage therapies are sold at a pharmacy in Georgia.

Therapies

Therapies DNA Virus Clinical Trials

Analysis Life Sciences Thank You Cannabis groups to Congress: FDA should regulate CBD as a dietary supplement

Agency IQ

AUGUST 25, 2023

BY ALEXANDER GAFFNEY, MS, RACAUG 22, 2023 10:19 PM CDT Regulatory background: How FDA regulates CBD Cannabidiol (CBD), a biologically active chemical compound derived from the Cannabis sativa plant, significantly benefited from the passage of the 2018 Farm Bill. The letter gave respondents until August 18, 2023 to respond to the request.

Regulations

Regulations FDA Science Production

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

DECEMBER 29, 2023

In 2023 there seemed to be an unusually large number of other decisions that are likely to have a substantial impact on what we or our clients do, but involve either different products, non-product claims, or both. In 2023, these include United States ex rel. 2023) (no medical monitoring in Delaware) ( here ); Brown v.

Testimonials

Testimonials FDA Drugs Vaccine

N.D. Cal. Sees No Standing or Merit in Eye Cosmetic Claims

Drug & Device Law

OCTOBER 25, 2023

Weigh any packaged meat at a grocery store, and there’s a decent chance the weight will be wrong. But every once in a while, a court will see through the consumer fraud case as itself being phony, and will throw the case out as if it was a package of spoiled meat. Colourpop Cosmetics, LLC , 2023 U.S. LEXIS 185688 (N.D.

FDA

FDA Packaging Production Regulations

Drug Discovery Digest

DrugBank adds ASHP data to knowledgebase, improving user experience and data reliability

Scandinavia: insight into opportunities for drug discovery

Trending Sources

European Commission vs Big Pharma, or profit vs access?

Article EMA Thank You New EC report dives deep to better understand shortages of critical medicines

Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023

Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023

Analysis Life Sciences Thank You After 13-year review, FDA finalizes ‘clear, conspicuous and neutral’ drug advertising rule

Analysis Life Sciences Thank You The 51 regulations that FDA is currently working on

Scaling Phage Therapy

Analysis Life Sciences Thank You Cannabis groups to Congress: FDA should regulate CBD as a dietary supplement

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

N.D. Cal. Sees No Standing or Merit in Eye Cosmetic Claims

Stay Connected